‹ CGEM latest research

CGEM (Cullinan Therapeutics, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed CGEM on 8 market nights between May 13, 2026 and September 17, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

8 calls 4 BUY · 4 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 4
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 17, 2026 HOLD $20.63 — / — -27.7% not yet
The scanner trigger (RSI Pullback) suggests a potential short-term bounce, but high risk prevents entry.
September 16, 2026 HOLD $20.54 — / — -18.2% not yet
Technical indicators show a strong uptrend with a bullish candle, above-average volume, and momentum turning up from oversold.
September 15, 2026 HOLD $20.40 — / — +5.5% -31.4%
Awaiting clarity on funding and risk mitigation before considering a directional trade.
September 14, 2026 HOLD $20.59 $21.61 / $17.92 +4.7% -26.7%
Awaiting a technical base to form near key support or a confirmed breakout above resistance before committing capital.
August 3, 2026 BUY $16.50 $19.80 / $14.03 +12.5% +35.8%
The setup is based on a technical oversold bounce with fundamental and sentiment tailwinds, suggesting a short-to-medium term trading opportunity.
June 25, 2026 BUY $17.65 $22.06 / $14.99 -4.6% -7.5%
The post-earnings drift signal suggests momentum could persist for several weeks.
May 14, 2026 BUY $16.33 — / — -13.4% -15.2%
Zipalertinib NDA acceptance and potential approval.
May 13, 2026 BUY $16.15 $20.19 / $13.73 -12.2% -20.5%
The current market regime is neutral, and while fundamentals and sentiment are bullish, technicals are neutral, and the risk score is high, necessitating a clear technical catalyst for entry.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.